Sruthi Gaddam, Pharm D
About Sruthi Gaddam, Pharm D
Sruthi Gaddam, Pharm.D., is a Rutgers Post-Doctoral Fellow currently working at Bristol-Myers Squibb in Hopewell, NJ. She holds an MBA in Pharmaceutical Marketing and Management from Rutgers Business School and a Doctor of Pharmacy from Rutgers University.
Title
Sruthi Gaddam currently holds the position of Rutgers Post-Doctoral Fellow at Bristol-Myers Squibb in Hopewell, NJ. In this role, she works on important projects related to pharmaceutical risk management, regulatory compliance, and safety signal identification.
Education and Expertise
Sruthi Gaddam has a professional background in pharmacy and business administration. She completed her Doctor of Pharmacy (Pharm.D.) at Rutgers, The State University of New Jersey-New Brunswick from 2009 to 2015. Following that, she pursued a Master of Business Administration (MBA) with a focus on Pharmaceutical Marketing and Management at Rutgers Business School, which she completed from 2016 to 2018. Her combined expertise in pharmacy and business allows her to contribute strategically in the pharmaceutical industry.
Work at Bristol-Myers Squibb
At Bristol-Myers Squibb, Sruthi Gaddam's responsibilities include coordinating updates to the Global Risk Management Plan for Opdivo, conducting Policy Evaluation and Regulatory Landscape Assessments, and ensuring compliance with new regulatory policies. She also coordinated the Orphan Drug Designation Application for Orencia and analyzed trends in health authority queries for Clinical Trial Applications, identifying causes of delay in approvals.
Regulatory Compliance and Safety Initiatives
Sruthi Gaddam has provided strategic input for various regulatory documents at Bristol-Myers Squibb, including aggregate safety reports, ad hoc responses, investigator brochures, and clinical overviews. She conducted a post-market epidemiology assessment for Orencia and contributed to the development of protocols for Post-authorization Safety Studies. As a Subject Matter Expert for Literature Review and Signal Detection, she also provides training to new colleagues on identifying safety signals in literature.